LatchBio
Data infrastructure for biotech
- 1-20 employees
- Healthcare
- B2B
- SaaS
- MedTech
- SoMa, San Francisco, CA
Jump to section
Company mission
To build and disseminate the data infrastructure of the biocomputing revolution.
Our take
Biological research innovations are leading to ever larger data heaps, and it is getting harder to analyze it all. Addressing this need, LatchBio helps to collate and analyze data from bio research using a Cloud Bioinformatics platform, end-to-end data organizer and workflow builder.
With backgrounds in big tech and data pipelining for the likes of Google and Twitter, the founders of LatchBio implemented their skills for the rapidly evolving world of biotech, taking the weight of biocomputation off the hands of the scientists running the tests. Having closed an early Series A funding round in June 2022, the company's switch from big data companies seems to be paying off.
As new discoveries are made, the problem might arise that LatchBio does not evolve its platform to keep up with the wide range of demands and variants in biological research. At the moment though, its platform - and the cost and time savings it delivers to its users - is turning heads and will be an exciting one to watch.
Kirsty
Company Specialist at Welcome to the Jungle
Funding (2 rounds)
Jun 2022
$28m
SERIES A
Oct 2021
$5m
SEED
Total funding: $33m
This company has top investors
Leadership
Alfredo Andere
(Co-Founder & CEO)Previously the President of Machine Learning at Berkeley, a Software Engineer at Google, and a Data Engineer at Facebook.
Kenny Workman
(Co-Founder & CTO)Previously a Machine Learning Engineer at Serotiny, a Software Engineer at Asimov, and a Researcher at Agile Biofoundry.
Kyle Goffin
(Co-Founder & COO)Previously the Editor in Chief at UC Berkeley Sutardja Center for Entrepreneurship and Technology, a Research and Publications Lead at Neurotech@Berkeley, and an Independent Analyst at DelMorgan & Co.
Articles
Jobs (2)
Software Engineering
Sales & Account Management